Skip to Main Content

Weight loss from bariatric surgery is associated with a reduced risk of cancer in study

Undergoing bariatric surgery in order to lose weight may substantially reduce some patients’ risk of cancer, according to a new study.

Cancer deaths among Black people drop, but still higher than other groups

Cancer death rates have steadily declined among Black people but remain higher than in other racial and ethnic groups, a new study shows.

Incoming JAMA editor says the journal’s issues handling race are ‘not unique to JAMA’

In her most pointed public comments since her selection as JAMA editor-in-chief, Kirsten Bibbins-Domingo acknowledged she had a visceral reaction to the podcast scandal that led to her predecessor’s departure. But ultimately, she wasn’t surprised.

After accusations of structural racism at JAMA, a Black health-equity advocate is named the journal’s editor

Kirsten Bibbins-Domingo, a Black internist and epidemiologist at the University of California, San Francisco, has been a leading voice for equitable health care during the Covid-19 pandemic.

STAT announces 46 inaugural STATUS List honorees

For Immediate Release: February 22, 2022 Media Contact: Maria Landron | [email protected] The STATUS List is the most definitive accounting of important and impactful individuals in health, medicine, and science With the premiere of “Augmented,” a bevy of notable hires, and now the STATUS List, STAT continues to expand its reach and influence BOSTON — STAT,…

Otis Brawley

A luminary in the battle against cancer, Brawley leads an effort at Johns Hopkins to study and eliminate racial disparities in cancer prevention, detection, and treatment. For 11 years, until late 2018, he was chief medical officer and executive vice president at the American Cancer Society, where he worked to reduce over-screening for cancer and…

JAMA editor-in-chief stepping down after backlash from podcast that questioned racism in medicine

Following a major backlash after JAMA aired a podcast and posted a tweet questioning whether structural racism exists in medicine, the journal’s editor-in-chief, Howard Bauchner, will be stepping down.

‘A natural experiment’: Pandemic-driven drop in cancer screening may aid research on overdiagnosis

The pandemic might provide a chance to settle a long-running controversy about how often, and in what circumstances, the downsides of cancer screening outweigh the benefits.

Racial disparities in Covid-19 are bad. They’re even worse in cancer

Eliminating racial disparities in clinical research and health care is even more important today, as precision medicine becomes an increasingly integral part of cancer and other care.

The story of a scientist’s mea culpa on Covid-19 vaccines — and a rough week on Twitter

Steven Salzberg, who proposed widespread Covid-19 vaccinations while Phase 3 trials are ongoing — and then issued a mea culpa — talks with @statnews about the experience.

A new FDA tool aims to inform cancer care, but experts say it has a glaring gap

A new platform gives cancer patients and physicians a way to comb through data on the experiences of clinical trial participants — but experts say it is missing critical demographic details.

FDA approves Gardasil 9, the HPV vaccine, to prevent head-and-neck cancer

For the past decade, evidence has suggested that Gardasil, the HPV vaccine, could stem an epidemic of throat cancer. The FDA has now approved its use for that purpose.

The debate over America’s drug-pricing system is built on myths. It’s time to face reality

America’s drug-pricing system is broken. The good news is that there are paths forward.

STAT Summit: The hypebusters who spoke truth to power

Hope or hype? In science, it can be easy to confuse the two. 

New evidence shows why the HPV vaccine is as important for boys as girls

A public health message fails to sink in, but new data show why it should: The HPV vaccine is as important for boys as girls.

STAT Summit 2019

Nov 20 & 21Cambridge, MA#STATSUMMIT About Catalyzing a revolution in human health Biology is changing the world. For almost four years, STAT has been reporting from the frontiers of medicine like no other publication. Now, Matthew Herper, Editorial Director of Events, and the rest of the STAT team are assembling top executives and researchers, policymakers,…

Grail, a deep-pocketed startup, shows ‘impressive,’ if early, results for cancer blood test

Grail, a deep-pocketed startup, outlines its plans for a blood test to detect cancer — and the early results seem encouraging.

Google’s AI improves accuracy of lung cancer diagnosis, study shows

In early testing, Google's #artificialintelligence system outperformed six radiologists in diagnosing lung cancer from reviewing a single CT scan.

With one manufacturer and little money to be made, supplies of a critical cancer drug are dwindling

There’s a critical national shortage of a #cancer drug that has been used for decades and that is a remarkably effective medicine.

Pharmalittle: Former Celgene CEO loses Senate bid; number of drug price hikes modest in October

The number of October 2018 price increases increased compared with September, but remained at a low level.

How a U.S. postal stamp helped fund a pivotal study on breast cancer

Countless breast cancer patients will be spared millions of dollars of chemotherapy thanks in part to something that millions of Americans did that cost them just pennies: bought a postage stamp.

Grail’s cancer blood test shows ‘proof of principle,’ but challenges remain

Will Grail hit its its out-of-the-park goal of detecting tumors super-early with a blood test? The early results are in for its liquid biopsy.

Heart group warns of cardiovascular risks after treatment for breast cancer

The American Heart Association warns that breast cancer survivors treated with common chemotherapies are at increased risk for heart disease.

Too much screening has misled us about real cancer risk factors, experts say

Another reason why excessive screening for cancer may be doing more harm than good.

Nearly half of U.S. cancer deaths blamed on unhealthy behavior

A new study finds that 45 percent of cancer deaths and 42 percent of diagnosed cancer cases could be attributed to "modifiable" risk factors.

15 percent of men regret prostate cancer treatment choices years later, study finds

Fifteen percent of men with localized prostate cancer regretted the decisions they made regarding treatment, with many citing sexual dysfunction.

At big cancer meeting, a big question: Is the U.S. ‘losing its edge’?

Less and less research presented at the ASCO cancer conference is supported by NIH: Is the US losing its leadership in biomedical research?

Diversify or else: This Missouri medical school’s urgent plan to save its accreditation

The University of Missouri School of Medicine has until 2018 to improve its minority numbers, and deans are doing a number of things to try and fix it.

Most cancer mutations arise from ‘bad luck,’ but many cases still preventable, researchers say

Most cancer-causing mutations arise from a cell making a random "bad luck" mistake in copying DNA, but that doesn't mean most cancers can't be prevented.